These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 8761899)
1. Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study. Jacob S; Rett K; Wicklmayr M; Agrawal B; Augustin HJ; Dietze GJ J Hypertens; 1996 Apr; 14(4):489-94. PubMed ID: 8761899 [TBL] [Abstract][Full Text] [Related]
2. Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients. Bell DS; Bakris GL; McGill JB Diabetes Obes Metab; 2009 Mar; 11(3):234-8. PubMed ID: 18564334 [TBL] [Abstract][Full Text] [Related]
4. The impact of carvedilol and metoprolol on serum lipid concentrations and symptoms in patients with hyperthyroidism. Ozbilen S; Eren MA; Turan MN; Sabuncu T Endocr Res; 2012; 37(3):117-23. PubMed ID: 22571552 [TBL] [Abstract][Full Text] [Related]
5. Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure. Hryniewicz K; Androne AS; Hudaihed A; Katz SD Circulation; 2003 Aug; 108(8):971-6. PubMed ID: 12912816 [TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness of carvedilol and propranolol on glycemic control and insulin resistance associated with L-thyroxin-induced hyperthyroidism--an experimental study. Bhatt P; Makwana D; Santani D; Goyal R Can J Physiol Pharmacol; 2007 May; 85(5):514-20. PubMed ID: 17632586 [TBL] [Abstract][Full Text] [Related]
7. Metabolic effects of beta-adrenoceptor antagonists with special emphasis on carvedilol. Kveiborg B; Christiansen B; Major-Petersen A; Torp-Pedersen C Am J Cardiovasc Drugs; 2006; 6(4):209-17. PubMed ID: 16913822 [TBL] [Abstract][Full Text] [Related]
8. Carvedilol but not metoprolol reduces beta-adrenergic responsiveness after complete elimination from plasma in vivo. Kindermann M; Maack C; Schaller S; Finkler N; Schmidt KI; Läer S; Wuttke H; Schäfers HJ; Böhm M Circulation; 2004 Jun; 109(25):3182-90. PubMed ID: 15184276 [TBL] [Abstract][Full Text] [Related]
9. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial). Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA; Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806 [TBL] [Abstract][Full Text] [Related]
10. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial. Zebrack JS; Munger M; Macgregor J; Lombardi WL; Stoddard GP; Gilbert EM Pharmacotherapy; 2009 Aug; 29(8):883-90. PubMed ID: 19637941 [TBL] [Abstract][Full Text] [Related]
11. Effect of carvedilol and metoprolol on blood pressure, blood flow, and vascular resistance. Morgan T; Snowden R; Butcher L J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S124-9. PubMed ID: 2454358 [TBL] [Abstract][Full Text] [Related]
12. Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers. Hanada K; Asari K; Saito M; Kawana J; Mita M; Ogata H Eur J Pharmacol; 2008 Jul; 589(1-3):194-200. PubMed ID: 18534575 [TBL] [Abstract][Full Text] [Related]
13. Body weight changes with beta-blocker use: results from GEMINI. Messerli FH; Bell DS; Fonseca V; Katholi RE; McGill JB; Phillips RA; Raskin P; Wright JT; Bangalore S; Holdbrook FK; Lukas MA; Anderson KM; Bakris GL; Am J Med; 2007 Jul; 120(7):610-5. PubMed ID: 17602935 [TBL] [Abstract][Full Text] [Related]
14. Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET). Torp-Pedersen C; Metra M; Charlesworth A; Spark P; Lukas MA; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Remme WJ; Scherhag A; Heart; 2007 Aug; 93(8):968-73. PubMed ID: 17237130 [TBL] [Abstract][Full Text] [Related]
15. The effect of beta-blocker use on cyclosporine level in cardiac transplant recipients. Bader FM; Hagan ME; Crompton JA; Gilbert EM J Heart Lung Transplant; 2005 Dec; 24(12):2144-7. PubMed ID: 16364863 [TBL] [Abstract][Full Text] [Related]
16. Effects of beta-blocker therapy on high sensitivity c-reactive protein, oxidative stress, and cardiac function in patients with congestive heart failure. Nagatomo Y; Yoshikawa T; Kohno T; Yoshizawa A; Anzai T; Meguro T; Satoh T; Ogawa S J Card Fail; 2007 Jun; 13(5):365-71. PubMed ID: 17602983 [TBL] [Abstract][Full Text] [Related]
17. Carvedilol versus metoprolol in the acute phase of myocardial infarction: Bonnemeier H; Ortak J; Tölg R; Witt M; Schmidt J; Wiegand UK; Bode F; Schunkert H; Richardt G Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S222-6. PubMed ID: 15683501 [TBL] [Abstract][Full Text] [Related]
18. Acute and long-term hemodynamic effects of carvedilol, a combined beta-adrenoceptor blocking and precapillary vasodilating agent, in hypertensive patients. Eggertsen R; Sivertsson R; Andrén L; Hansson L J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S97-100. PubMed ID: 2454378 [TBL] [Abstract][Full Text] [Related]
19. Do metoprolol and carvedilol have equivalent effects on diurnal heart rate in patients with chronic heart failure? Sanderson JE; Leung LY; Chan SK; Yip GW; Fung JW; Yu CM Eur J Heart Fail; 2005 Aug; 7(5):874-7. PubMed ID: 16043407 [TBL] [Abstract][Full Text] [Related]
20. The effects of 2 beta-receptor blocking agents on the microcirculation of healthy subjects and of hypertensive patients. Albrecht M; Haustein KO Int J Clin Pharmacol Ther; 1997 Dec; 35(12):580-6. PubMed ID: 9455718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]